Elucid Biopharma
About Us
Strategy - Insights - Decision Making
Big decisions are difficult. The mission of Elucid Biopharma as a life sciences advisory firm is to make critical choices easier.
Our career experience, spanning big pharma and start-up biotech firms, has been that making key decisions is often an agonizing process marked by uncertainty and fear. Elucid Biopharma will get to the heart of the matter and help decision makers to get the right information at the right time.
We know the right questions to ask in order to obtain the critical data, and to devise an effective plan. We will fill information gaps, identify the best evidence available, and provide the pivotal insights for key decision elements.
Our approach is thorough and targeted to each client’s unique situation and needs.
Meet The Team
Background and Experience
Jens H.P. Kasperzik, PharmD, MBA
​
Entrepreneur
-
Co-founded and managed biopharmaceutical start-up
-
Built team of world-class experts
-
Conceptualized and implemented key business initiatives
-
Authored and filed pivotal regulatory documents
-
Provided commercialization and business development consulting services to early-stage pharma companies
Global Brand Leader, CANCIDAS
-
Launched breakthrough Antifungal to hospital audiences worldwide; grew sales from $100 million to >$600 million
Global Launch Team, VIOXX
-
Launched novel, blockbuster pain and arthritis medication worldwide
Product Manager, RENITEC / CO-RENITEC
-
Maintained market leadership for one of the company’s top brands in competitive German market
Business Development: Transaction Management and Asset Evaluation
-
Negotiated and executed transactions including acquisitions, divestitures, licensing, restructurings, third party collaborations
-
Evaluated ~200 licensing and M&A targets for Merck & Co.
Joseph H. Kavanagh, BSs, MBA
​
Entrepreneur
-
Co-founded and gained funding for multiple biopharmaceutical startup and early-stage ventures up to 86 Million USD Series A
-
Drove commercialization decision process for pipeline assets that enabled pivotal go/no-go decision making
-
Provided commercialization and strategic market planning insight to early and commercialization stage companies
Global Commercial Leader, GAMUNEX (IVIG)
-
Led the global launch strategy development and planning for Orphan/Rare disease indication and LCM planning for flagship product
-
Launched novel, blockbuster pain and arthritis medication worldwide
Global Launch Team Leader (SEBIVO/TYZEKA) HBV
-
Led global marketing and launch planning and execution for product that was approved in 50 countries
Global Senior Brand Product Promotion Manager (ARCOXIA) Pain
-
Conceptualized, planned, and led the development and implementation of global promotional strategy
